PAR5 COST-EFFECTIVENESS OF RITUXIMAB AS A NEW TREATMENT MODALITY FOR RHEUMATOID ARTHRITIS IN GERMANY
May 1, 2006, 00:00 AM
10.1016/S1098-3015(10)64386-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64386-0/fulltext
Section Title :
Section Order :
287
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64386-0&doi=10.1016/S1098-3015(10)64386-0